Our portfolio company Genalyte just announced the award of a government grant from the National Cancer Institute for the development of a diagnostic system using Genalyte’s proprietary biomarker technology (see Genalyte Expands into Cancer Profiling with $1 Million NCI Grant to Develop Cancer Biomarker Panel). This project is a significant validation of the company’s capability […]Read More
Earlier this week one of our portfolio companies, Genalyte, Inc., announced the release of a groundbreaking diagnostic system for early detection of Type 1 diabetes. This is of special significance to me as the young daughter of a good friend almost died due to undiagnosed Type 1 Diabetes – she was discovered by her parents […]Read More
Top 5 pathways to personalized medicine Healthcare IT NewsJeff RoweJuly 22, 2013 If there’s one thing everyone in healthcare can probably agree on right now, it’s that there is an awful lot of data being generated each and every day. What to do with that data, however, is another question. As Ted Driscoll, digital health […]Read More
February 20, 2013 source: the original post by Ed Silverman appeared in Pharmalot As drug development and diagnostics increasingly converge, the advent of personalized medicine is increasing all the time. Of course, we are not quite there yet, but the advent of electronic medical records and the genome are inching us closer all the time. But […]Read More
I am happy to announce today that Ted Driscoll, formerly a technology partner at Claremont Creek Ventures, has been promoted to Director and will lead the Digital Healthcare team. Driscoll’s new appointment is effective immediately. (you can read the full press release here) In his tenure with us, Driscoll has sourced and led four healthcare […]Read More
July 11, 2012 source: MedCity News Ted was recently interview by MedCity News for two articles: Biggest threat to investment in mobile health startups? Not enough unique intellectual property VCs say a coachable entrepreneur, strong IP make convergence worth investing in Here are some excerpts from the interviews: Biggest threat to investment in mobile health […]Read More
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.